Leukemia
A Phase II multi-center, open-label, single-arm dose escalation study of Asciminib monotherapy in 2nd and 1st Line Chronic Phase - Chronic Myelogenous Leukemia (ASC2ESCALATE)(CABL001AUS08)
- Details
ClinicalTrials.gov ID:
NCT05384587
Diagnosis Type:
NA
USOR Number:
- Address
22 W Dry Creek Circle
Littleton, CO 80120
P: (303) 730-4700